1. Krishna Institute of Medical Sciences
stock logo

100% Buy

Krishna Institute of Medical Sciences Share Price

KIMS

₹2,055.00+₹0.85 (0.04%) TodayLast updated on 24 Jun, 2024 | 03:29 PM IST
₹2,031.75₹2,071.25
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹16,299 Crs

Open

₹2,049.15

Close

₹2,054.15

Circuit range

₹2,465.75 - ₹1,643.85

Day range

₹2,031.75 - ₹2,071.25

Year range

₹1,720.00 - ₹2,356.40

Volume

26,886

Avg. traded

₹2,052.57

Revenue (12m)

₹2,498 Crs

Krishna Institute of Medical Sciences

Krishna Institute of Medical Sciences, or KIMS, is a corporate healthcare group, with hospitals in Telangana, Andhra Pradesh and Maharashtra. It provides multi-disciplinary integrated healthcare services with a focus on tertiary and quaternary healthcare.

KIMS was initially established as Jagjit Singh and Sons Private Limited in 1973 in Mumbai. Later, in 2004, the company's name was changed to Krishna Institute of Medical Sciences Private Limited. Until 2003, Jagjit Singh and some of his family members solely owned, managed and controlled the company. In February 2003, certain promoters of the company, including Dr Bhaskar Rao Bollineni and Krishnaiah Bollineni, along with other individuals and entities, acquired the entire equity share capital of the company.

KIMS began its journey in Nellore, Andhra Pradesh, establishing its oldest hospital with a capacity of about 200 beds. Two years later, in 2002, the group expanded its presence by inaugurating another hospital in Rajahmundry, Andhra Pradesh. KIMS hospital, located in Secunderabad, was established in 2004 and has a capacity of 1,000 beds, as per a CRISIL Report.

The main hospitals in Secunderabad and Rajahmundry have received accreditation from the National Accreditation Board for Hospitals and Healthcare Providers India (NABH).

Over the years, the group ventured into various cities in Andhra Pradesh and Maharashtra, apart from Telangana. In 2021, KIMS acquired a stake in Hyderabad-based Sunshine Hospitals. The following year, in 2022, it expanded its footprint by signing an MoU with Dr Raj Nagarkar, a surgical oncologist in western Maharashtra, to establish KIMS Manavata Hospital, a multi-specialty facility in Nashik with a total bed capacity of 325. KIMS also acquired a majority stake in Kingsway Hospitals in Nagpur in 2022. KIMS went public in 2021 with its initial public offering (IPO), transitioning into a public company.

The market capitalisation of Krishna Institute of Medical Sciences Limited is over ₹18,300 crore as of February 28, 2024. KIMS share price has gained over 70% in the last one year.

Business Operations

KIMS manages 12 multispecialty hospitals, providing a wide array of healthcare services across more than 40 specialities and super specialities. These include cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and childcare.

The Sunshine Hospitals which came into the hands of KIMS generated a revenue contribution of 19%. The KIMS SUNSHINE will be shifted soon to the company’s premises which will add 300 new beds. FY 2023 FY marked the group's foray into Maharashtra at important centres like Nagpur and Nashik through strategic alliances. The Nagpur unit brought another 330+ beds.

The company is all set to enter Karnataka in the ensuing year with a 250-bed hospital in the heart of Bengaluru. There are immediate plans to expand its wings to Thane, Mumbai in the next year. All these initiatives will lead to a doubling of its capacity to 8,000 beds in the next 2-3 years spanning across the states of Telangana, AP, Maharashtra and Karnataka.

Financial Highlights

– Krishna Institute of Medical Sciences Limited's revenue for the financial year 2023 stood at ₹2,198 crore, up 33% compared to ₹1,651 crore in FY22. – The net profit after tax for the financial year 2022-23 was ₹367 crore compared to ₹344 crore during the previous year. – In FY23, the earnings before interest, tax, depreciation and amortisation (EBITDA) increased to ₹577 crore from the previous year's ₹512 crore. – The company's earnings per share (EPS) stood at ₹42.03 in FY23 compared to ₹41.88 in the previous financial year.

Krishna Institute of Medical Sciences Key indicators

arrow

52 week high

₹2,356.40

52 week low

₹1,720.00

P/E ratio

52.55

P/B ratio

8.9

ROE

16.79%

ROCE

22.58%

Dividend yield

--

Debt/Equity ratio

EPS

31.55

Learn more

Investment checklist: (4/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

100%

Hold

0%

Sell

0%

This analysis is based on the reviews of 5 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

34.22%

Net profit margin

22.3%

ROE

16.79%

ROA

14.94%

ROCE

22.58%

Learn more

Krishna Institute of Medical Sciences Shareholder returns

arrow

1 day

-0.75%

1 week

+2.37%

1 month

+6.29%

3 months

+2.57%

1 year

+18.81%

3 years

+106.04%

5 years

+106.04%

Krishna Institute of Medical Sciences Share Price history

arrow
DayOpenCloseDay’s change
Fri, Jun 21 2024
₹2,087.55
₹2,054.15
-0.75%
Thu, Jun 20 2024
₹2,110.00
₹2,069.65
-1.12%
Wed, Jun 19 2024
₹2,055.80
₹2,093.15
+2.60%
Tue, Jun 18 2024
₹2,053.15
₹2,040.10
+0.17%
Fri, Jun 14 2024
₹2,030.00
₹2,036.70
+1.50%
Thu, Jun 13 2024
₹1,978.30
₹2,006.55
+2.10%
Wed, Jun 12 2024
₹1,931.90
₹1,965.35
+2.42%
Tue, Jun 11 2024
₹1,880.00
₹1,918.85
+3.04%

Shareholding info

arrow

Promoters (38.82%)

Mutual Funds (26.33%)

Retail and other (11.32%)

Foreign institutions-FII (16.73%)

Other domestic institutions (6.8%)

Promoters

Learn more

Frequently asked questions